# reload+after+2024-01-21 16:37:59.264558
address1§One St Peters Square
city§Manchester
zip§M2 3DE
country§United Kingdom
website§https://www.genincode.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies. The company's molecular tests combine clinical algorithms and artificial intelligence to provide advanced patient risk assessment to predict disease onset. Its tests include Cardio inCode, a patented genetic test to help user to adopt cardiovascular prevention steps; Lipid inCode, a genetic diagnostic test for familial hypercholesterolemia; SUDD inCode, a genetic test to diagnose the cause of sudden cardiac death and familial heart disease; Thrombo inCode, a genetic test for diagnosis of hereditary thrombophilia and the risk of thrombosis; and Thrombo inCode Reproductive Health, a genetic test that offers information related to risk of thrombophilia and associated risks for future pregnancies. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom.
fullTimeEmployees§34
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Matthew Heaton Walls', 'age': 59, 'title': 'Co-Founder, CEO & Director', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 336540, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jordi  Puig Gilberte', 'title': 'Co-Founder, COO & Director', 'fiscalYear': 2022, 'totalPay': 149163, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Paul Andrew Peter Foulger', 'age': 53, 'title': 'CFO, Company Secretary & Director', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 150070, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.417
priceToSalesTrailing12Months§2.9314609
currency§GBp
forwardEps§-3.28
exchange§LSE
quoteType§EQUITY
shortName§GENINCODE PLC ORD 1P
longName§GENinCode Plc
firstTradeDateEpochUtc§1626937200
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§db3d9297-bde4-3616-9e4b-7f03c12b021b
targetHighPrice§27.0
targetLowPrice§27.0
targetMeanPrice§27.0
targetMedianPrice§27.0
recommendationMean§1.0
recommendationKey§strong_buy
numberOfAnalystOpinions§1
quickRatio§5.825
grossMargins§0.47551998
ebitdaMargins§0.0
trailingPegRatio§None
